A recent study by researchers at Penn State College of Medicine found significant racial disparities in the age of systemic lupus erythematosus (SLE) patients at the time of hospital admission for cardiovascular disease (CVD) events and CVD-related …
Researchers have identified a genetic “signature,” a series of genes that are activated by interferon in patients with severe systemic lupus erythematosus (SLE). This is the first time a signature pattern of gene expression has been identified in an autoimmune disease. The identification of this genetic signature may be used in the future to help diagnose lupus, predict the development of serious disease, and perhaps most importantly in treatment decisions.